This global conference was designed to accelerate the development of innovative treatments for Alzheimer’s disease (AD), related dementias and cognitive aging. The ADDF’s funded investigators and top level scientists in the field presented on their current research progress and stimulated discussion.  The conference provided ample opportunity for scientists to network, form collaborations, and share information and resources. The meeting attracted 135 key stakeholders from the pharmaceutical, biotechnology, government and academic communities.

For more information, please visit our Conference Website